ENDEAVOR BIOMEDICINES

Lobbying client · California · filed 2025 to 2026

Biotechnology & therapeutics

$263,500 Reported spend

7 Filings counted

1 Firms hired

1 Bills named

Spend is reported income plus in-house expenses across 7 filings. Everything on this page is grouped by the client's LDA id (66301), not by name.

Firms hired 1

AVIVA STRATEGIES (FKA MGB CONSULTING) $263,500 7 filings

Bills named in these filings 1

HR 7953
FAIR ACT

1 filing

Reported by year 2 years

2026 $102,000 2 filings
2025 $161,500 5 filings

Issues lobbied 2

Health Issues 6
Science/Technology 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

HOUSE OF REPRESENTATIVES 6
SENATE 6
Food & Drug Administration (FDA) 4

Recent filings 7 total

Q2

AVIVA STRATEGIES (FKA MGB CONSULTING)

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $51,000 income · posted Jul 17, 2026

View → Q1

AVIVA STRATEGIES (FKA MGB CONSULTING)

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $51,000 income · posted Apr 15, 2026

View → Q4

AVIVA STRATEGIES (FKA MGB CONSULTING)

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $51,000 income · posted Jan 15, 2026

View → Q3

AVIVA STRATEGIES (FKA MGB CONSULTING)

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $51,000 income · posted Oct 15, 2025

View → Q2

AVIVA STRATEGIES (FKA MGB CONSULTING)

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $51,000 income · posted Jul 16, 2025

View → Q1

AVIVA STRATEGIES (FKA MGB CONSULTING)

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $8,500 income · posted May 6, 2025

View → RR

AVIVA STRATEGIES (FKA MGB CONSULTING)

2nd Quarter (Apr 1 - June 30) 2025 · posted Apr 25, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.